MORRISVILLE, N.C. (Business Wire) FEBRUARY 18, 2015 – Clinipace Worldwide, a global, digital clinical research organization (dCRO), today announced the addition of industry veteran Fred B. Davenport, Jr., to its Board of Directors.
As an independent director, Fred brings to Clinipace a significant pedigree in scaling global organizations within the CRO industry, having spent 10 years at Pharmaceutical Product Development, Inc. (PPD) during its rapid growth phase, followed by 6 years on the Board of Directors for Medpace, Inc. At PPD, Fred served in various roles, including General Counsel, Executive Vice President, and President. During that time, he was responsible for global operations and numerous support functions, including Phase 1-4 clinical operations in the Americas, Europe, and Asia, global laboratory services, quality management, intellectual technology, strategic development, human resources, facilities, purchasing, and legal.
As a partner with Murchison, Taylor & Gibson, PLLC in Wilmington, NC, Fred now focuses his legal practice on mergers and acquisitions and general corporate representation.
“We are incredibly excited about Fred joining our Board as we plan for the next phase of our growth and development. In our industry, few have the hands-on experience of scaling a company to the levels Fred has achieved. We look forward not only to his operational guidance, but also his M&A expertise as we begin to deploy fresh capital,” commented Jeff Williams, CEO, Clinipace Worldwide.
“It is time for the industry to embrace improved service delivery models that reduce executional risks through improved visibility,” said Davenport. “I have been watching Clinipace for some time, and I believe they are correctly focused on this challenge with their dCRO model. I am thrilled to be able to contribute to this endeavor.”
Fred earned his BA, JD and MBA degrees from The University of North Carolina at Chapel Hill. He is a member of the North Carolina state bar as well as a member of the New Hanover County, North Carolina and American Bar Associations.
About Clinipace Worldwide
Clinipace Worldwide, a digital contract research organization (dCRO), pioneered an innovative, technology-amplified CRO service model to serve the unique needs of venture-backed, mid-tier, and strategic pharmaceutical, biotechnology, and medical device firms.
Powered by Clinipace’s proprietary TEMPO™ eClinical platform and a team of experts with extensive knowledge in therapeutic areas such as oncology, cardiovascular, and metabolic diseases, gastroenterology, infectious diseases, nephrology, immunology, and vaccines, the company assists life science firms in successfully executing regulatory strategies, clinical development, and post-approval research programs.
Clinipace Worldwide global headquarters are based in Research Triangle Park, NC, with additional domestic operations in Overland Park, KS, and Boulder, CO. Additional offices are located across the globe in Switzerland, Germany, the United Kingdom, Taiwan, China, South Korea, Hong Kong, Vietnam, Singapore, Malaysia, Brazil, Argentina, Israel, and India. For more information, visit http://www.clinipace.com.